Lv2
110 积分 2024-11-14 加入
Safety and Efficacy of Combination PRaG Regimen with Dynamic and Precise Regulation of Thymalfasin Dose Based on T Lymphocyte Count for the Treatment of Chemo-Refractory Metastatic Solid Tumors: An Open-Label Phase II Trial (PRaG 5.0 Study)
3个月前
已关闭
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
8个月前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
8个月前
已完结
Evolution of claudin18.2 therapies in gastroesophageal cancers
10个月前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer A Randomized Clinical Trial
1年前
已关闭
皖公网安备34019202002308
